Under the partnership, Lilly will pay IU up to $40 million to build clinical trial infrastructure, accelerate access to neurology care and train IU students.

Eli Lilly and Indiana University (IU) have announced a new agreement, under which Lilly will provide up to $40m to IU in ...

Eli Lilly and Co. and Indiana University on Wednesday announced a new agreement that would see the Indianapolis-based drugmaker to provide up to $40 million over five years to the university to ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

INDIANAPOLIS (WISH) — Indianapolis-based pharmaceutical giant Eli Lilly and Co. has committed up to $40 million to Indiana University to expand access to clinical trials and innovative treatments for ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...

Developed in partnership with agency Wieden+Kennedy Portland, Lilly’s Good Days officially launched on Sunday. The spot will air in the final slot before showings of Wicked: For Good and during the ...